Trial intelligence / Profile preview

Cooperative Study of Factor VIII Inhibitors

NCT00000582Phase 3Completed

Sponsor
National Heart, Lung, and Blood Institute
Start
Jul 1978
Modality
Replacement Enzymes
01

Overview

A Phase 3 trial of coagulation factor ix in hemophilia A, sponsored by National Heart, Lung, and Blood Institute. Started Jul 1978; status: completed.

02

Drugs

coagulation factor ix
03

Conditions

hemophilia A

Beyond the preview

Go deeper on NCT00000582.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000582.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call